Cell Cycle Regulation of the c-Myc Transcriptional Activation Domain

REFERENCES

• Adams, R. L. P., and J. G. Lindsay. 1967. Hydroxyurea: reversal of inhibition and use as a cell-synchronizing agent. J. Biol. Chem. 242:1314–1317.
   PubMed Web of Science ®Google Scholar
• Alvarez, E., I. C. Northwood, F. A. Gonzalez, D. A. Latour, A. Seth, C. Abate, T. Curran, and R. J. Davis. 1991. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation: characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J. Biol. Chem. 266:15277–15285.
   PubMed Web of Science ®Google Scholar
• Amati, B., M. W. Brooks, N. Levy, T. D. Littlewood, G. I. Evan, and H. Land. 1993. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233–245.
   PubMed Web of Science ®Google Scholar
• Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (London) 359:423–426.
   PubMed Web of Science ®Google Scholar
• Amin, C., A. J. Wagner, and N. Hay. 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13:383–390.
   PubMed Web of Science ®Google Scholar
• Armelin, H. A., M. C. S. Armelin, K. Kelly, T. Stewart, P. Leder, B. H. Cochran, and C. D. Stiles. 1984. Functional role for c-myc in mitogenic response to platelet derived growth factor. Nature (London) 310:655–660.
   PubMed Web of Science ®Google Scholar
• Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcrip-tional activity. Cell 72:211–222.
   PubMed Web of Science ®Google Scholar
• Bar-Ner, M., L. T. Messing, C. M. Cultraro, M. J. Birrer, and S. Segal. 1992. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Cell Growth Differ. 3:183–190.
   PubMedGoogle Scholar
• Barrett, C. B., E. Erikson, and J. L. Mailer. 1992. A purified S6 kinase kinase from Xenopus eggs activates S6 kinase II and autophosphorylates on serine, threonine, and tyrosine residues. J. Biol. Chem. 267:4408–4415.
   PubMedGoogle Scholar
• Berberich, S. J., and M. D. Cole. 1992. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/ Max heterodimers. Genes Dev. 6:166–176.
   PubMed Web of Science ®Google Scholar
• Birrer, M. J., L. Raveh, H. Dosaka, and S. Segal. 1989. A transfected L-myc gene can substitute for c-myc in blocking murine erythroleukemia differentiation. Mol. Cell. Biol. 9:2734–2737.
   PubMed Web of Science ®Google Scholar
• Bissonnette, R. P., F. Echeverri, A. Mahboubi, and D. R. Green. 1992. Apoptic cell death induced by c-myc is inhibited by bcl-2. Nature (London) 359:552–556.
   PubMed Web of Science ®Google Scholar
• Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisen-man, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149–1151.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., and R. N. Eisenman. 1991. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211–1217.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., L. Kretzner, and R. N. Eisenman. 1992. Myc and Max function as a nucleoprotein complex. Curr. Opin. Genet. Dev. 2:227–235.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., B. Luscher, and R. N. Eisenman. 1992. Myc and Max associate in vivo. Genes Dev. 6:71–80.
   PubMed Web of Science ®Google Scholar
• Boulton, T. G., S. H. Nye, D. J. Robbins, N. Y. Ip, E. Radziejewska, S. D. Morgenbesser, R. A. DePinho, N. Panay-otatos, M. H. Cobb, and G. D. Yancopoulos. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 68:663–675.
   Google Scholar
• Boulton, T. G., G. D. Yancopoulos, J. S. Gregory, C. Slaughter, C. Moomaco, J. Hsu, and M. H. Cobb. 1990. An insulin stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science 249:64–67.
   PubMed Web of Science ®Google Scholar
• Clark-Lewis, I., J. S. Sanghera, and S. L. Pelech. 1991. Definition of a consensus sequence for peptide substrate rec-ognition by p44mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266:15180–15184.
   PubMedGoogle Scholar
• Cobb, M. H., T. G. Boulton, and D. J. Robbins. 1991. Extra-cellular signal-regulated kinases: ERKs in progress. Cell Regul. 2:965–978.
   PubMedGoogle Scholar
• Coffey, R. J., Jr., C. C. Bascom, N. J. Sipes, R. Graves-Deal, B. E. Weissman, and H. L. Moses. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol. Cell. Biol. 8:3088–3093.
   PubMed Web of Science ®Google Scholar
• Cole, M. D. 1986. The myc oncogene: its role in transformation and differentiation. Annu. Rev. Genet. 20:361–384.
   PubMed Web of Science ®Google Scholar
• Cole, M. D. 1991. Myc meets its Max. Cell 65:715–716.
   PubMedGoogle Scholar
• Copolla, J. S., and M. D. Cole. 1986. Constitutive c-myc oncogene expression blocks mouse erythroleukemia cell differentiation but not commitment. Nature (London) 320:760–763.
   PubMedGoogle Scholar
• Countaway, J. L., I. C. Northwood, and R. J. Davis. 1989. Mechanism of phosphorylation of the epidermal growth factor receptor at threonine 669. J. Biol. Chem. 264:10828–10835.
   PubMedGoogle Scholar
• Coyle, M. B., and B. Strauss. 1970. Cell killing and the accumulation of breaks in the DNA of HEp-2 cells incubated in the presence of hydroxyurea. Cancer Res. 30:2314–2319.
   PubMed Web of Science ®Google Scholar
• Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J. 11:1797–1804.
   PubMed Web of Science ®Google Scholar
• Dean, M., R. A. Levine, W. Ran, M. S. Kindy, G. E. Sonnen-shein, and J. Campisi. 1986. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J. Biol. Chem. 261:9161–9166.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffen, H. Piwnica-Worms, C.-H. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085–1095.
   PubMed Web of Science ®Google Scholar
• Dmitrovsky, E., W. M. Kuehl, G. F. Hollis, I. R. Kirsch, T. P. Bender, and S. Segal. 1986. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleu-kaemia cell line. Nature (London) 322:748–750.
   PubMed Web of Science ®Google Scholar
• Dotto, G. P., M. Z. Gilman, M. Maruyama, and R. A. Wein-berg. 1986. c-myc and c-fos expression in differentiating mouse primary keratinocytes. EMBO J. 5:2853–2857.
   PubMed Web of Science ®Google Scholar
• Downs, K. M., G. R. Martin, and J. M. Bishop. 1989. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 3:860–869.
   PubMed Web of Science ®Google Scholar
• Dulic, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin E with a periodic Gl-S phase protein kinase. Science 257:1958–1961.
   PubMed Web of Science ®Google Scholar
• Eilers, M., D. Picard, K. R. Yamamoto, and J. M. Bishop. 1989. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (London) 340:66–68.
   PubMedGoogle Scholar
• Eilers, M., S. Schrim, and J. M. Bishop. 1991. The Myc protein activates transcription of the a-prothymosin gene. EMBO J. 10:133–141.
   PubMed Web of Science ®Google Scholar
• Eisenman, R. N., C. Y. Tachibana, H. D. Abrams, and S. R. Hann. 1985. v-myc- and c-myc-encoded proteins are associated with the nuclear matrix. Mol. Cell. Biol. 5:114–126.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119–128.
   PubMed Web of Science ®Google Scholar
• Ferrell, J. E., M. Wu, J. C. Gerhart, and G. S. Martin. 1991. Cell cycle tyrosine phosphorylation of p34cdc2 and a MAP-kinase homolog in Xenopus oocytes and eggs. Mol. Cell. Biol. 11:1965–1971.
   PubMed Web of Science ®Google Scholar
• Freytag, S. O., C. V. Dang, and W. M. F. Lee. 1990. Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Growth Differ. 1:339–343.
   PubMedGoogle Scholar
• Gille, H., A. D. Sharrocks, and P. E. Shaw. 1992. Phosphory-lation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature (London) 358:414–417.
   PubMed Web of Science ®Google Scholar
• Gonzalez, F. A., D. L. Raden, and R. J. Davis. 1991. Identifi-cation of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266:22159–22163.
   PubMed Web of Science ®Google Scholar
• Goodrich, D. W., and W.-H. Lee. 1992. Abrogation by c-myc of Gl phase arrest induced by RB protein but not by p53. Nature (London) 360:177–179.
   PubMedGoogle Scholar
• Gotoh, Y., K. Moriyama, S. Matsuda, E. Okamura, T. Kishi-moto, H. Kawasaki, K. Suzuki, and E. Nishida. 1991. Xenopus M phase MAP kinase: isolation of its cDNA and activation by MPF. EMBO J. 10:2661–2668.
   PubMed Web of Science ®Google Scholar
• Gotoh, Y., E. Nishide, S. Matsuda, N. Shiina, H. Kosako, K. Shiokawa, T. Akiyama, K. Ohta, and H. Sakai. 1991. Purification and properties of an M-phase activated MAP kinase from Xenopus oocytes and its effects on microtubule dynamics in vitro. Nature (London) 349:251–254.
   PubMed Web of Science ®Google Scholar
• Gupta, S., A. Seth, and R. J. Davis. 1993. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc. Natl. Acad. Sci. USA 90:3216–3220.
   PubMed Web of Science ®Google Scholar
• Gurley, L. R., R. A. Walters, and R. A. Tobey. 1975. Sequential phosphorylation of histone subtractions in the Chinese hamster cell cycle. J. Biol. Chem. 250:3936–3944.
   PubMedGoogle Scholar
• Gutman, A., and B. Wasylyk. 1991. Nuclear targets for tran-scription regulation by oncogenes. Trends Genet. 7:49–54.
   PubMedGoogle Scholar
• Halazonetis, T. D., and A. N. Kandil. 1991. Determination of the c-Myc DNA binding site. Proc. Natl. Acad. Sci. USA 88:6162–6166.
   PubMedGoogle Scholar
• Hann, S. R., C. B. Thompson, and R. N. Eisenman. 1985. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature (London) 314:366–369.
   PubMed Web of Science ®Google Scholar
• Heikkila, R., G. Schwab, E. Wickstrom, S. L. Loke, D. H. Pluznik, R. Watt, and L. M. Neckers. 1987. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0-G1. Nature (London) 328:445–449.
   PubMed Web of Science ®Google Scholar
• Holt, J. T., R. L. Redner, and A. W. Nienhuis. 1988. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol. Cell. Biol. 8:963–973.
   PubMed Web of Science ®Google Scholar
• Hourdry, J., A. Brulfert, M. Gusse, D. Schoevaert, M. V. Taylor, and M. Mechali. 1988. Localization of c-myc expres-sion during oogenesis and embryonic development in Xenopus laevis. Development 104:631–641.
   PubMedGoogle Scholar
• Hunter, T. 1991. Cooperation between oncogenes. Cell 64:249–270.
   PubMed Web of Science ®Google Scholar
• Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70:375–387.
   PubMed Web of Science ®Google Scholar
• Jackson, S. P. 1992. Regulating transcription factor activity by phosphorylation. Trends Cell. Biol. 2:104–108.
   PubMedGoogle Scholar
• Jafiredo, T., B. Vandenbunder, and F. Dieterlen-Lievre. 1989. In situ study of c-Myc protein expression during avian development. Development 105:679–695.
   PubMedGoogle Scholar
• Kaelin, W. G., Jr., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A binding region of the retinoblastoma gene product. Cell 64:521–532.
   PubMed Web of Science ®Google Scholar
• Kara, J., J. V. Watson, A. D. Lowe, S. M. Green, and W. Vedeckis. 1989. Regulation of cell cycle duration by c-myc levels. Oncogene 4:773–787.
   PubMedGoogle Scholar
• Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914–5920.
   PubMed Web of Science ®Google Scholar
• Kato, G. J., and C. V. Dang. 1992. Function of the c-Myc oncoprotein. FASEB J. 6:3065–3072.
   PubMed Web of Science ®Google Scholar
• Kato, G. J., W. M. F. Lee, L. Chen, and C. V. Dang. 1992. Max: functional domains and interaction with c-Myc. Genes Dev. 6:81–92.
   PubMed Web of Science ®Google Scholar
• Kelly, K., B. H. Cochran, C. D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35:603–610.
   PubMed Web of Science ®Google Scholar
• Kerkhoff, E., K. Bister, and K. H. Klempnauer. 1991. Se-quence-specific DNA binding by Myc proteins. Proc. Natl. Acad. Sci. USA 88:4323–4327.
   PubMed Web of Science ®Google Scholar
• King, M. W., J. M. Roberts, and R. N. Eisenman. 1986. Expression of the c-myc proto-oncogene during development of Xenopus laevis. Mol. Cell. Biol. 6:4499–4508.
   PubMed Web of Science ®Google Scholar
• Kohl, N. E., and H. R. Ruley. 1987. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes. Oncogene 2:41–48.
   PubMed Web of Science ®Google Scholar
• Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activi-ties. Nature (London) 359:426–429.
   PubMedGoogle Scholar
• Kume, T. U., S. Takada, and M. Obinata. 1988. Probability that the commitment of murine erythroleukemia cell differen-tiation is determined by the c-myc level. J. Mol. Biol. 202:779–786.
   PubMedGoogle Scholar
• Langdon, W. Y., A. W. Harris, and S. Cory. 1988. Growth of E|i-myc B-lymphoid cells in vitro and their evolution towards autonomy. Oncogene Res. 3:271–279.
   PubMedGoogle Scholar
• Iin, L.-L., M. Wartmann, A. Y. Lin, J. L. Knopf, A. Seth, and R. J. Davis. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269–278.
   PubMedGoogle Scholar
• Luscher, B., and R. N. Eisenman. 1990. New light on Myc and Myb, part 1. Myc. Genes & Dev. 4:2025–2035.
   PubMed Web of Science ®Google Scholar
• Luscher, B., and R. N. Eisenman. 1992. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J. Cell Biol. 118:775–784.
   PubMedGoogle Scholar
• Luscher, B., E. A. Kuenzel, E. G. Krebs, and R. N. Eisenman. 1989. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J. 8:1111–1119.
   PubMedGoogle Scholar
• Makela, T. P., P. J. Koskinen, I. Vastrik, and K. Alitalo. 1992. Alternative forms of Max as enhancers or suppressors of Myc-Ras cotransformation. Science 256:373–377.
   PubMed Web of Science ®Google Scholar
• Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809–860.
   PubMed Web of Science ®Google Scholar
• Maruyama, K. S., S. Schiavi, W. Huse, G. L. Johnson, and E. Ruley. 1987. myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation. Oncogene 1:361–367.
   PubMed Web of Science ®Google Scholar
• Mittnacht, S., and R. A. Weinberg. 1991. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381–393.
   PubMed Web of Science ®Google Scholar
• Norbury, C., and P. Nurse. 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441–470.
   PubMed Web of Science ®Google Scholar
• Northwood, I. C, F. A. Gonzalez, M. Wartmann, D. L. Raden, and R. J. Davis. 1991. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669. J. Biol. Chem. 266:15266–15276.
   PubMed Web of Science ®Google Scholar
• Palmieri, S., P. Kahn, and T. Graf. 1983. Quail embryo fibroblasts transformed by four v-myc containing virus isolates show enhanced proliferation but are non-tumorigenic. EMBO J. 2:2385–2389.
   PubMed Web of Science ®Google Scholar
• Papoulas, O., N. G. Williams, and R. E. Kingston. 1992. DNA binding activities of c-Myc purified from eukaryotic cells. J. Biol. Chem. 267:10470–10480.
   PubMed Web of Science ®Google Scholar
• Pedrali-Noy, G., S. Soadari, A. Miller-Faures, A. O. A. Miller, J. Kruppa, and G. Koch. 1980. Synchronization of HeLa cell cultures by inhibition of DNA polymerase a with aphidicolin. Nucleic Acids Res. 8:377–387.
   PubMedGoogle Scholar
• Penn, L. J. Z., E. M. Laufer, and H. Land. 1990. c-Myc: evidence for multiple regulatory functions. Semin. Cancer Biol. 1:69–87.
   PubMedGoogle Scholar
• Pietenpol, J. A., K. Miinger, P. M. Howley, R. W. Stein, and H. Moses. 1991. Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor pi and by the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 88:10227–10231.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., R. W. Stein, E. Moran, P. Yacluk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785.
   PubMed Web of Science ®Google Scholar
• Pines, J., and T. Hunter. 1991. Human cyclins A and Bl are differentially located in the cell and undergo cell cycle-depen-dent nuclear transport. J. Cell. Biol. 115:1–17.
   PubMed Web of Science ®Google Scholar
• Posada, J., and J. A. Cooper. 1992. Requirements for phosphorylation of MAP kinase during meiosis in Xenopus oocytes. Science 255:212–215.
   PubMedGoogle Scholar
• Posada, J., J. Sanghera, S. L. Pelech, R. Aefersold, and J. A. Cooper. 1991. Tyrosine phosphorylation and activation of homologous protein kinases during oocyte maturation and mitogenic activation of fibroblasts. Mol. Cell. Biol. 11:2517–2528.
   PubMedGoogle Scholar
• Prendergast, G. C, R. Hopewell, B. J. Gorham, and E. B. Ziff. 1992. Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. Genes Dev. 6:2429–2439.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C, D. Lawe, and E. B. Ziff. 1991. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras co-transformation. Cell 65:395–407.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C, and E. B. Ziff. 1991. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251:186–189.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C, and E. B. Ziff. 1992. A new bind for Myc. Trends Genet. 8:91–96.
   PubMedGoogle Scholar
• Prochownik, E. V., and J. Kukowska. 1986. Deregulated ex-pression of c-myc by murine erythroleukemia cells prevents differentiation. Nature (London) 322:848–850.
   PubMed Web of Science ®Google Scholar
• Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R. Woodgett. 1991. Phosphorylation of c-Jun mediated by MAP kinases. Nature (London) 353:670–674.
   PubMed Web of Science ®Google Scholar
• Rabbitts, P. H., J. W. Watson, A. Lamond, A. Forster, M. A. Stinson, G. Evan, W. Fischer, E. Athertton, M. A. Sheppard, and T. H. Rabbitts. 1985. Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 4:2009–2015.
   PubMed Web of Science ®Google Scholar
• Roussel, M. F., J. L. Cleveland, S. A. Shurtleff, and C. J. Sherr. 1991. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature (London) 353:361–363.
   PubMed Web of Science ®Google Scholar
• Rustgi, A. K., N. Dyson, and R. Bernards. 1991. Amino-terminal domains of c-Myc and N-Myc proteins mediate bind-ing to the retinoblastoma gene product. Nature (London) 352:541–544.
   PubMed Web of Science ®Google Scholar
• Saksela, K., T. P. Makela, K. Hughes, J. R. Woodgett, and K. Alitalo. 1992. Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site. Oncogene 7:347–352.
   PubMedGoogle Scholar
• Sanghera, J., H. B. Paddon, and S. L. Pelech. 1991. Role of protein phosphorylation in the maturation-induced activation of a myelin basic protein kinase from sea star oocytes. J. Biol. Chem. 266:6700–6707.
   PubMedGoogle Scholar
• Seth, A., E. Alvarez, S. Gupta, and R. J. Davis. 1991. A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J. Biol. Chem. 266:23521–23524.
   PubMedGoogle Scholar
• Seth, A., F. A. Gonzalez, S. Gupta, D. L. Raden, and R. J. Davis. 1992. Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267:24796–24804.
   PubMedGoogle Scholar
• Shi, Y., J. M. Glynn, L. J. Guilbert, T. G. Cotter, R. P. Bissonnette, and D. R. Green. 1992. Role for c-myc in activation-induced apoptic cell death in T cell hybridomas. Science 257:212–214.
   PubMed Web of Science ®Google Scholar
• Shibuya, E. K., T. G. Boulton, M. H. Cobb, and J. V. Ruderman. 1992. Activation of p42 MAP kinase and the release of oocytes from cell cycle arrest. EMBO J. 11:3963–3975.
   PubMed Web of Science ®Google Scholar
• Shibuya, H., M. Yoneyama, J. Ninomiya-Tsuji, K. Matsumoto, and T. Taniguchi. 1992. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 70:57–67.
   PubMed Web of Science ®Google Scholar
• Sorrentino, V., M. D. Drozdoff, M. D. McKinney, L. Zeitz, and E. Fleissner. 1986. Potentiation of growth factor activity by exogeneous c-myc expression. Proc. Natl. Acad. Sci. USA 83:8167–8171.
   PubMedGoogle Scholar
• Stern, D. F., A. B. Roberts, N. S. Roche, M. B. Sporn, and R. A. Weinberg. 1986. Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor. Mol. Cell. Biol. 6:870–877.
   PubMed Web of Science ®Google Scholar
• Stokoe, D., P. Campbell, S. Nakielny, H. Hidaka, S. J. Leevers, C. J. Marshall, and P. Cohen. 1992. MAPKAP kinase-2; a novel protein kinase activated by mitogen-actfvated protein kinase. EMBO J. 11:3985–3994.
   PubMedGoogle Scholar
• Street, A. J., E. Blackwood, B. Luscher, and R. N. Eisenman. 1990. Mutational analysis of the carboxy-terminal casein ki-nase II phosphorylation site in human c-Myc. Curr. Top. Microbiol. Immunol. 166:251–258.
   PubMedGoogle Scholar
• Sturgill, T. W., L. B. Ray, E. Erikson, and J. L. Mailer. 1988. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature (London) 354:715–718.
   Google Scholar
• Takishima, K., I. Griswold-Prenner, T. Ingebritsen, and M. R. Rosner. 1991. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase. Proc. Natl. Acad. Sci. USA 88:2520–2524.
   PubMedGoogle Scholar
• Tamemoto, H., T. Kadowaki, K. Tobe, K. Ueki, T. Izumi, Y. Chatani, M. Kohno, M. Kasuga, Y. Yazaki, and Y. Akanuma. 1992. Biphasic activation of two mitogen-actfvated protein kinases during the cell cycle in mammalian cells. J. Biol. Chem. 267:20293–20297.
   PubMed Web of Science ®Google Scholar
• Tate, E. H., M. E. Wilder, S. Cram, and W. Wharton. 1983. A method for staining 3T3 cell nuclei with propidium iodide in hypotonic solution. Cytometry 4:211–215.
   PubMedGoogle Scholar
• Thompson, C. B., P. B. Challoner, P. E. Neiman, and M. Groudine. 1985. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature (London) 314:363–366.
   PubMed Web of Science ®Google Scholar
• Tobey, R. A., N. Oishi, and H. A. Crissman. 1990. Cell cycle synchronization: reversible induction of G2 synchrony in cul-tured rodent and human diploid fibroblasts. Proc. Natl. Acad. Sci. USA 87:5104–5108.
   PubMedGoogle Scholar
• Torres, R., N. Schreiber-Agus, S. D. Morgenbesser, and R. A. Depinho. 1992. Myc and Max: a putative transcriptional com-plex in search of a cellular target. Curr. Opin. Cell Biol. 4:468–474.
   PubMedGoogle Scholar
• Waitz, W., and P. Loidl. 1991. Cell cycle dependent associa-tion of c-Myc protein with the nuclear matrix. Oncogene 6:29–35.
   PubMedGoogle Scholar
• Waters, C. M., T. D. Littlewood, D. C. Hancock, J. P. Moore, and G. I. Evan. 1991. c-Myc protein expression in untrans-formed fibroblasts. Oncogene 6:797–805.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1991. Tumor suppressor genes. Science 254:1138–1146.
   PubMed Web of Science ®Google Scholar
• Woodford, T. A., and A. B. Pardee. 1986. Histone HI kinase in exponential and synchronous populations of Chinese hamster fibroblasts. J. Biol. Chem. 261:4669–4676.
   PubMedGoogle Scholar
• Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxil, a protein that specifically interacts with Max to bind Myc-Max recogni-tion sites. Cell 72:223–232.
   PubMed Web of Science ®Google Scholar